Home lactate meter and glucose meter accuracy in GSD
Part of Genetic & congenital, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests how well a home lactate meter and a standard blood sugar meter work for people with certain types of Glycogen Storage Disease (GSD Ia, Ib, or XI). If you or your child has one of these types, joining could help improve home monitoring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with Glycogen Storage Disease type Ia, Ib, or XI, confirmed by a liver biopsy or genetic test.
- For children: a parent or legal guardian must be able to understand and sign a consent form.
- For adolescents: you must agree to take part (assent).
- For adults: you must be able to understand and sign a consent form yourself.
- You cannot have an unspecified type of GSD.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a simple finger-stick lactate meter gives accurate results for children and adults with a specific type of glycogen storage disease (GSD Ia). It aims to find a faster, easier way to monitor health during emergency visits or hospital stays.
This study tests whether a carbohydrate counting method helps children with glycogen storage disease type 1 (GSD1) better manage their blood sugar, improve quality of life, and affect certain biomarkers. It may help families learn a new way to plan meals and stabilize glucose levels.
This study uses a glucose monitor (a small sensor you wear) to measure how your blood sugar responds after eating raw cornstarch, a common treatment for glycogen storage disease type I. The goal is to understand how well cornstarch helps keep your blood sugar steady.
This trial tests different diet strategies to help adults with GSDI (a metabolic condition also known as von Gierke disease) maintain stable blood sugars and avoid dangerous drops. It may help you learn how to better manage your condition through diet.
This trial tests whether a medicine called diazoxide can help treat type 1 glycogenosis, a rare metabolic condition that affects how the body stores and uses sugar. Participation is limited to patients already being followed at one of two French hospitals.
This study tests an experimental medicine called BEAM-301 for people with a specific form of glycogen storage disease type Ia (GSDIa). The goal is to see if it can help reduce dangerous low blood sugar episodes.
Hear when a new Glycogen Storage Disease Type Ia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.